ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder
Jason Noel
American Journal of Health-system Pharmacy, 2020
View PDFchevron_right
Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia
Jari Tiihonen
JAMA Psychiatry, 2019
View PDFchevron_right
Effectiveness of clozapine in treatment-resistant schizophrenia
Raguraman Janakiraman
Indian Journal of Psychiatry, 2005
View PDFchevron_right
The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review
Fabian Lungu
Brain sciences, 2024
View PDFchevron_right
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
George Garibaldi
Schizophrenia Research, 2013
View PDFchevron_right
Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients
Eva Peñas Lledó
European Journal of Clinical Pharmacology, 2007
View PDFchevron_right
When Symptoms Persist: Choosing Among Alternative Somatic Treatments for Schizophrenia
George Christison
Schizophrenia Bulletin, 1991
View PDFchevron_right
Efficacy and Safety of Pharmacological and Psychological Interventions for the Treatment of Psychosis and Schizophrenia in Children, Adolescents and Young Adults: A Systematic Review and Meta-Analysis
Chris Hollis
PLOS ONE, 2015
View PDFchevron_right
Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics
Takefumi Suzuki
Journal of Clinical Psychopharmacology, 2018
View PDFchevron_right
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder
Eckart Ruether
Journal of Psychiatric Research, 2011
View PDFchevron_right
Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness
Gretchen Haas
Journal of Psychiatric Research, 1998
View PDFchevron_right
Efficacy and safety of clozapine combination with different antipsychotics in schizophrenia: a systematic review
Zullies Ikawati
Indonesian Journal of Pharmacology and Therapy, 2024
View PDFchevron_right
Long-Acting Risperidone and Oral Antipsychotics in Schizophrenia
Robert Rosenheck
New England Journal of Medicine, 2011
View PDFchevron_right
Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia
S. Kleisas
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010
View PDFchevron_right
Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)
Michael Davidson
American Journal of Psychiatry, 2009
View PDFchevron_right
A meta-analysis of effectiveness of real-world studies of antipsychotics in schizophrenia: Are the results consistent with the findings of randomized controlled trials?
István Bitter
Translational Psychiatry
View PDFchevron_right
Infectious agents associated with schizophrenia: A meta-analysis
Jorge Cervilla
Schizophrenia Research, 2012
View PDFchevron_right
Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial
James Gold
Archives of General Psychiatry, 2007
View PDFchevron_right
Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses
B. Mutamba
Health Economics Review, 2012
View PDFchevron_right
Maintenance antipsychotic medication patterns in outpatient schizophrenia patients: a naturalistic cohort study
Richard Laugharne
Acta Psychiatrica Scandinavica, 2006
View PDFchevron_right
Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study
Robert Rosenheck
Schizophrenia Research, 2008
View PDFchevron_right
Inconclusive Evidence for the Efficacy of Olanzapine in the Treatment of Negative Symptoms in Schizophrenia
Brendan Murphy
The Journal of Clinical Psychiatry, 2008
View PDFchevron_right
A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia
mohammad reza khodaie
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
View PDFchevron_right
Clinical Course, Neurobiology and Therapeutic Approaches to Treatment Resistant Schizophrenia. Toward an Integrated View
Arsime Demjaha
Frontiers in Psychiatry, 2019
View PDFchevron_right
Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate
Karina Hansen
International Journal of Neuropsychopharmacology, 2016
View PDFchevron_right